Human Hematopoietic Stem And Progenitor Antigen And Methods For Its Use
AssigneeAmCell Corporation
InventorsAmy H. Yin, Sheri Miraglia, David W. Buck
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmCell Corporation
InventorsAmy H. Yin, Sheri Miraglia, David W. Buck
Estimating the term…
A hematopoietic progenitor cell antigen and reagents, notably antibodies, that specifically bind to the antigen are provided. Expression of the antigen is highly tissue specific. It is only detected on a subset of hematopoietic progenitor cells derived from human bone marrow, fetal bone marrow and liver, cord blood and adult peripheral blood. The subset of cells recognized by AC133 is CD34bright and contains substantially all of the CFU-GM activity present in the CD34+ population. This highly specific distribution of AC133 makes it exceptionally useful as a reagent for isolating and characterizing human hematopoietic progenitor and stem cells. Cells selected for expression of AC133 antigen can be further purified by selection for other hematopoietic stem cell and progenitor cell markers.
1-51. (canceled)
A composition comprising (a) an isolated cell expressing an AC133 cell surface antigen having SEQ ID NO:2 and (b) a reagent that specifically binds the AC133 antigen, wherein the reagent is complexed with the AC133 antigen.
Dependencies are inferred from the claim text.